“Opinion: Time for Greater Transparency in Critical 340B Federal Drug Pricing Program”

The 340B Drug Pricing Program was created by Congress in 1992 to allow nonprofit healthcare providers with limited resources to ensure access to medicines for uninsured patients with acute and chronic health conditions and disorders.